Intracellular and transdermal protein delivery mediated by non-covalent interactions with a synthetic guanidine-rich molecular carrier

Jungkyun Im, Sanket Das, Dongjun Jeong, Chang Jin Kim, Hyun-Suk Lim, Ki Hean Kim, Sung Kee Chung

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The impermeability of the cell plasma membrane is one of the major barriers for protein transduction into mammalian cells, and it also limits the use of proteins as therapeutic agents. Protein transduction has usually been achieved based on certain invasive processes or cell penetrating peptides (CPP). Herein we report our study in which a synthetic guanidine-rich molecular carrier is used as a delivery vector for intracellular and transdermal delivery of proteins. First a sorbitol-based molecular carrier having 8 guanidine units (Sor-G8) was synthesized, and then was simply mixed with a cargo protein of varying sizes to form the non-covalent complex of carrier-cargo proteins. These ionic complexes were shown to have efficient cellular uptake properties. The optimum conditions including the molar ratio between cargo protein and carrier, and the treatment time have been defined. Several protein cargoes were successfully examined with differing sizes and molecular weights: green fluorescent protein (MW 27 kDa), albumin (66 kDa), concanavalin A (102 kDa), and immunoglobulin G (150 kDa). These non-covalent complexes were also found to have excellent transdermal penetration ability into the mouse skin. The skin penetration depth was studied histologically by light microscopy as well as two-photon microscopy thus generating a depth profile. These complexes were largely found in the epidermis and dermis layers, i.e. down to ca. 100 μm depth of the mouse skin. Our synthetic Sor-G8 carrier was found to be substantially more efficient that Arg8 in both the intracellular transduction and the transdermal delivery of proteins. The mechanism of the cellular uptake of the complex was briefly studied, and the results suggested macropinocytosis.

Original languageEnglish (US)
Pages (from-to)646-654
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume528
Issue number1-2
DOIs
StatePublished - Aug 7 2017
Externally publishedYes

Fingerprint

Guanidine
Proteins
Skin
Microscopy
Carrier Proteins
Cell Membrane
Cell-Penetrating Peptides
Sorbitol
Dermis
Concanavalin A
Green Fluorescent Proteins
Photons
Epidermis
Albumins
Immunoglobulin G
Molecular Weight
Light

Keywords

  • Molecular transporter
  • Non-covalent linkage
  • Protein delivery
  • Synthetic molecular carrier
  • Transdermal delivery

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Intracellular and transdermal protein delivery mediated by non-covalent interactions with a synthetic guanidine-rich molecular carrier. / Im, Jungkyun; Das, Sanket; Jeong, Dongjun; Kim, Chang Jin; Lim, Hyun-Suk; Kim, Ki Hean; Chung, Sung Kee.

In: International Journal of Pharmaceutics, Vol. 528, No. 1-2, 07.08.2017, p. 646-654.

Research output: Contribution to journalArticle

Im, Jungkyun ; Das, Sanket ; Jeong, Dongjun ; Kim, Chang Jin ; Lim, Hyun-Suk ; Kim, Ki Hean ; Chung, Sung Kee. / Intracellular and transdermal protein delivery mediated by non-covalent interactions with a synthetic guanidine-rich molecular carrier. In: International Journal of Pharmaceutics. 2017 ; Vol. 528, No. 1-2. pp. 646-654.
@article{66e68c6ac4c24731859dbf67529032cc,
title = "Intracellular and transdermal protein delivery mediated by non-covalent interactions with a synthetic guanidine-rich molecular carrier",
abstract = "The impermeability of the cell plasma membrane is one of the major barriers for protein transduction into mammalian cells, and it also limits the use of proteins as therapeutic agents. Protein transduction has usually been achieved based on certain invasive processes or cell penetrating peptides (CPP). Herein we report our study in which a synthetic guanidine-rich molecular carrier is used as a delivery vector for intracellular and transdermal delivery of proteins. First a sorbitol-based molecular carrier having 8 guanidine units (Sor-G8) was synthesized, and then was simply mixed with a cargo protein of varying sizes to form the non-covalent complex of carrier-cargo proteins. These ionic complexes were shown to have efficient cellular uptake properties. The optimum conditions including the molar ratio between cargo protein and carrier, and the treatment time have been defined. Several protein cargoes were successfully examined with differing sizes and molecular weights: green fluorescent protein (MW 27 kDa), albumin (66 kDa), concanavalin A (102 kDa), and immunoglobulin G (150 kDa). These non-covalent complexes were also found to have excellent transdermal penetration ability into the mouse skin. The skin penetration depth was studied histologically by light microscopy as well as two-photon microscopy thus generating a depth profile. These complexes were largely found in the epidermis and dermis layers, i.e. down to ca. 100 μm depth of the mouse skin. Our synthetic Sor-G8 carrier was found to be substantially more efficient that Arg8 in both the intracellular transduction and the transdermal delivery of proteins. The mechanism of the cellular uptake of the complex was briefly studied, and the results suggested macropinocytosis.",
keywords = "Molecular transporter, Non-covalent linkage, Protein delivery, Synthetic molecular carrier, Transdermal delivery",
author = "Jungkyun Im and Sanket Das and Dongjun Jeong and Kim, {Chang Jin} and Hyun-Suk Lim and Kim, {Ki Hean} and Chung, {Sung Kee}",
year = "2017",
month = "8",
day = "7",
doi = "10.1016/j.ijpharm.2017.06.030",
language = "English (US)",
volume = "528",
pages = "646--654",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Intracellular and transdermal protein delivery mediated by non-covalent interactions with a synthetic guanidine-rich molecular carrier

AU - Im, Jungkyun

AU - Das, Sanket

AU - Jeong, Dongjun

AU - Kim, Chang Jin

AU - Lim, Hyun-Suk

AU - Kim, Ki Hean

AU - Chung, Sung Kee

PY - 2017/8/7

Y1 - 2017/8/7

N2 - The impermeability of the cell plasma membrane is one of the major barriers for protein transduction into mammalian cells, and it also limits the use of proteins as therapeutic agents. Protein transduction has usually been achieved based on certain invasive processes or cell penetrating peptides (CPP). Herein we report our study in which a synthetic guanidine-rich molecular carrier is used as a delivery vector for intracellular and transdermal delivery of proteins. First a sorbitol-based molecular carrier having 8 guanidine units (Sor-G8) was synthesized, and then was simply mixed with a cargo protein of varying sizes to form the non-covalent complex of carrier-cargo proteins. These ionic complexes were shown to have efficient cellular uptake properties. The optimum conditions including the molar ratio between cargo protein and carrier, and the treatment time have been defined. Several protein cargoes were successfully examined with differing sizes and molecular weights: green fluorescent protein (MW 27 kDa), albumin (66 kDa), concanavalin A (102 kDa), and immunoglobulin G (150 kDa). These non-covalent complexes were also found to have excellent transdermal penetration ability into the mouse skin. The skin penetration depth was studied histologically by light microscopy as well as two-photon microscopy thus generating a depth profile. These complexes were largely found in the epidermis and dermis layers, i.e. down to ca. 100 μm depth of the mouse skin. Our synthetic Sor-G8 carrier was found to be substantially more efficient that Arg8 in both the intracellular transduction and the transdermal delivery of proteins. The mechanism of the cellular uptake of the complex was briefly studied, and the results suggested macropinocytosis.

AB - The impermeability of the cell plasma membrane is one of the major barriers for protein transduction into mammalian cells, and it also limits the use of proteins as therapeutic agents. Protein transduction has usually been achieved based on certain invasive processes or cell penetrating peptides (CPP). Herein we report our study in which a synthetic guanidine-rich molecular carrier is used as a delivery vector for intracellular and transdermal delivery of proteins. First a sorbitol-based molecular carrier having 8 guanidine units (Sor-G8) was synthesized, and then was simply mixed with a cargo protein of varying sizes to form the non-covalent complex of carrier-cargo proteins. These ionic complexes were shown to have efficient cellular uptake properties. The optimum conditions including the molar ratio between cargo protein and carrier, and the treatment time have been defined. Several protein cargoes were successfully examined with differing sizes and molecular weights: green fluorescent protein (MW 27 kDa), albumin (66 kDa), concanavalin A (102 kDa), and immunoglobulin G (150 kDa). These non-covalent complexes were also found to have excellent transdermal penetration ability into the mouse skin. The skin penetration depth was studied histologically by light microscopy as well as two-photon microscopy thus generating a depth profile. These complexes were largely found in the epidermis and dermis layers, i.e. down to ca. 100 μm depth of the mouse skin. Our synthetic Sor-G8 carrier was found to be substantially more efficient that Arg8 in both the intracellular transduction and the transdermal delivery of proteins. The mechanism of the cellular uptake of the complex was briefly studied, and the results suggested macropinocytosis.

KW - Molecular transporter

KW - Non-covalent linkage

KW - Protein delivery

KW - Synthetic molecular carrier

KW - Transdermal delivery

UR - http://www.scopus.com/inward/record.url?scp=85021167858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021167858&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2017.06.030

DO - 10.1016/j.ijpharm.2017.06.030

M3 - Article

VL - 528

SP - 646

EP - 654

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -